Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Pharmacokinetic Models in Prostate Cancer

European Radiology - Germany
doi 10.1007/s00330-010-2037-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Contrast Agents in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Oncotarget
Oncology
2017English

Techniques and Applications of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Cancer

2014English

Prostate Cancer Detection With Magnetic Resonance Imaging: Is Dynamic Contrast-Enhanced Imaging Necessary in Addition to Diffusion-Weighted Imaging?

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2010English

Improving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Investigative Radiology
MedicineNuclear MedicineRadiologyImaging
2014English

Accuracy of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: Systematic Review and Meta-Analysis

Oncotarget
Oncology
2017English

Pharmacokinetic Analysis for the Differentiation of Pituitary Microadenoma Subtypes Through Dynamic Contrast‑enhanced Magnetic Resonance Imaging

Oncology Letters
Cancer ResearchOncology
2019English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of OATP Dysfunction in Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Texture Features and Pharmacokinetic Parameters in Differentiating Benign and Malignant Breast Lesions by Dynamic Contrast Enhanced Magnetic Resonance Imaging

Oncology Letters
Cancer ResearchOncology
2018English

Imaging Tumor Vascular Heterogeneity and Angiogenesis Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Clinical Cancer Research
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy